Provention Bio PRVB
$ 24.98
0.0%
Annual report 2022
added 03-29-2023
Provention Bio Balance Sheet 2011-2024 | PRVB
Annual Balance Sheet Provention Bio
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-20.4 M | -77.5 M | - | -39.2 M | -58.5 M | -21.8 M | - | - | - | - | - | - |
Long Term Debt |
23.5 M | 590 K | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
151 K | 125 K | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | 998 K | - | - | - | - | - | - |
Total Current Liabilities |
90.4 M | 22.8 M | 16.7 M | 3.84 M | 1.87 M | - | - | - | - | - | - | - |
Total Liabilities |
115 M | 24.9 M | 17.4 M | 3.84 M | 1.87 M | 2.28 M | 290 K | - | - | - | - | - |
Deferred Revenue |
17.7 M | 5.6 M | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-406 M | -292 M | -178 M | -79.1 M | -35.8 M | -9.3 M | -165 K | - | - | - | - | - |
Total Assets |
237 M | 136 M | 129 M | 86 M | 61.5 M | 22.4 M | 125 K | - | - | - | - | - |
Cash and Cash Equivalents |
44 M | 78.2 M | 102 M | 39.2 M | 58.5 M | 21.8 M | - | - | - | - | - | - |
Book Value |
122 M | 111 M | 111 M | 82.2 M | 59.7 M | 20.2 M | -165 K | - | - | - | - | - |
Total Shareholders Equity |
122 M | 111 M | 111 M | 82.2 M | 59.7 M | -6.03 M | -165 K | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Provention Bio
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | 23.3 M | - | 555 K | 590 K | 624 K | 655 K | 686 K | 715 K | 715 K | 715 K | 715 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | 49.1 M | - | 28.3 M | 24.9 M | 23.8 M | 25.3 M | 29.9 M | 17.4 M | 17.4 M | 17.4 M | 17.4 M | 3.84 M | - | - | - | 1.87 M | 1.23 M | 2.99 M | - | 2.28 M | 2.28 M | 2.28 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | 7.78 M | - | 7.37 M | 5.6 M | 5.49 M | 7 M | 4.52 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | -372 M | - | -314 M | -292 M | -266 M | -239 M | -210 M | -178 M | -178 M | -178 M | -178 M | -79.1 M | -79.1 M | -79.1 M | -79.1 M | -35.8 M | -35.8 M | -35.8 M | -35.8 M | -9.3 M | -9.3 M | -9.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | 194 M | - | 122 M | 136 M | 158 M | 183 M | 214 M | 129 M | 129 M | 129 M | 129 M | 86 M | 86 M | 86 M | 86 M | 61.5 M | 61.5 M | 61.5 M | 61.5 M | 22.4 M | 22.4 M | 22.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | 102 M | - | 74.9 M | 78.2 M | 139 M | 152 M | 180 M | 102 M | 102 M | 102 M | 102 M | 39.2 M | 39.2 M | 39.2 M | 39.2 M | 58.5 M | 58.5 M | 58.5 M | 58.5 M | 21.8 M | 21.8 M | 21.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | 145 M | - | 94.2 M | 111 M | 134 M | 158 M | 184 M | 111 M | 111 M | 111 M | 111 M | 82.2 M | 86 M | 86 M | 86 M | 59.7 M | 60.3 M | 58.5 M | 61.5 M | 20.2 M | 20.2 M | 20.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | 145 M | - | 94.2 M | 111 M | 134 M | 158 M | 184 M | 111 M | 111 M | 111 M | 111 M | 82.2 M | 82.2 M | 82.2 M | 82.2 M | 59.7 M | 59.7 M | 59.7 M | 59.7 M | -6.03 M | -6.03 M | -6.03 M | - | -165 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency